OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
ALCRB58

Carbios SA

Commodity ChemicalsVerified

Carbios maintains a strong liquidity position with a current ratio of 9.94, indicating that its current assets significantly exceed its current liabilities. The company's debt-to-equity ratio is 0.16, suggesting a conservative capital structure with minimal reliance on debt financing. However, the company reported negative operating cash flow of -15.66 million USD, which may indicate ongoing operational challenges or high reinvestment needs. In terms of profitability, Carbios has not provided specific metrics such as net margin or return on equity, which are typically used in the Commodity Chemicals industry to assess performance. Without these figures, it is difficult to directly compare Carbios's profitability to the industry median. Carbios's revenue concentration is not disclosed in the provided data, making it challenging to assess the company's exposure to specific segments or geographic regions. The lack of detailed segment reporting limits the ability to evaluate the diversification of its revenue streams. The company's growth trajectory is not clearly defined in the provided data. Analysts have assigned a mean price target of 9.00, with a median and high price target also at 9.00, suggesting a consensus on the stock's potential value. However, the mean recommendation of 3.00 indicates a neutral stance, with no strong buy or buy ratings. Carbios faces low liquidity and dilution risks according to the risk assessment. There are no immediate filing-based liquidity or dilution flags, which suggests that the company is not currently under financial pressure that would necessitate issuing new shares or taking on additional debt. Recent events related to Carbios are not detailed in the provided data. The company's financial snapshot does not include information on recent filings or transcripts that could provide insight into management's strategy or operational updates.

30-day price · ALCRB-0.88 (-10.6%)
Low$7.22High$8.79Close$7.38As of16 May, 00:00 UTC
Profile
CompanyCarbios SA
TickerALCRB.PA
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Carbios SA is a biotechnology company focused on the development and commercialization of enzymatic recycling technologies for plastic waste and the production of bio-based chemicals.

Classification. Carbios is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry with a confidence level of 0.92.

Carbios maintains a strong liquidity position with a current ratio of 9.94, indicating that its current assets significantly exceed its current liabilities. The company's debt-to-equity ratio is 0.16, suggesting a conservative capital structure with minimal reliance on debt financing. However, the company reported negative operating cash flow of -15.66 million USD, which may indicate ongoing operational challenges or high reinvestment needs. In terms of profitability, Carbios has not provided specific metrics such as net margin or return on equity, which are typically used in the Commodity Chemicals industry to assess performance. Without these figures, it is difficult to directly compare Carbios's profitability to the industry median. Carbios's revenue concentration is not disclosed in the provided data, making it challenging to assess the company's exposure to specific segments or geographic regions. The lack of detailed segment reporting limits the ability to evaluate the diversification of its revenue streams. The company's growth trajectory is not clearly defined in the provided data. Analysts have assigned a mean price target of 9.00, with a median and high price target also at 9.00, suggesting a consensus on the stock's potential value. However, the mean recommendation of 3.00 indicates a neutral stance, with no strong buy or buy ratings. Carbios faces low liquidity and dilution risks according to the risk assessment. There are no immediate filing-based liquidity or dilution flags, which suggests that the company is not currently under financial pressure that would necessitate issuing new shares or taking on additional debt. Recent events related to Carbios are not detailed in the provided data. The company's financial snapshot does not include information on recent filings or transcripts that could provide insight into management's strategy or operational updates.
Key takeaways
  • Carbios has a strong liquidity position with a current ratio of 9.94.
  • The company's capital structure is conservative, with a debt-to-equity ratio of 0.16.
  • Analysts have assigned a neutral mean recommendation of 3.00 for the stock.
  • There are no immediate liquidity or dilution risks identified for the company.
  • The company's profitability and growth trajectory are not clearly defined in the provided data.
  • # RATIONALES
  • **margin_outlook_rationale**: The company's margin outlook is uncertain due to the lack of specific profitability metrics in the provided data.
  • **rd_outlook_rationale**: The outlook for research and development is not specified, as the data does not include R&D spending or related projections.
Financial snapshot
PeriodHA-latest
CurrencyUSD
Revenue
Gross profit
Operating income
Net income
R&D
SG&A
D&A
SBC
Operating cash flow-$15.7M
CapEx
Free cash flow
Total assets$232.5M
Total liabilities$38.3M
Total equity$194.2M
Cash & equivalents$51.7M
Long-term debt$31.6M
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$194.2M
Net cash$20.0M
Current ratio9.9
Debt/Equity0.2
ROA
ROE
Cash conversion
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Chemicals · cohort 1439 companies
MetricALCRBActivity
Op margin5.5% medp25 -0.0% · p75 10.8%
Net margin4.1% medp25 0.1% · p75 8.8%
Gross margin20.5% medp25 12.4% · p75 29.7%
R&D / revenue1.5% medp25 1.0% · p75 2.1%
CapEx / revenue-6.2% medp25 -13.4% · p75 -2.6%
Debt / equity16.0%37.1% medp25 10.3% · p75 82.0%below median
Observations
IR observations
Mean price target9.00
Median price target9.00
High price target9.00
Low price target9.00
Mean recommendation3.00 (1=strong buy, 5=strong sell)
Strong-buy count0.00
Buy count0.00
Hold count1.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate-1.19
Mean revenue estimate6,000,000
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod financials
no public URL
2026-05-15 00:17 UTC#25de733d
Source: analysis-pipeline (hybrid)Generated: 2026-05-27 07:43 UTCJob: 37516e98